Dr. Martens plc (LON:DOCS - Get Free Report) shares rose 24.7% during trading on Thursday . The company traded as high as GBX 75.30 ($1.02) and last traded at GBX 74.75 ($1.01). Approximately 8,151,296 shares were traded during mid-day trading, an increase of 262% from the average daily volume of 2,251,775 shares. The stock had previously closed at GBX 59.95 ($0.81).
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada decreased their target price on Dr. Martens from GBX 7,000 ($94.75) to GBX 6,000 ($81.21) and set a "sector perform" rating for the company in a research report on Monday, May 19th.
Read Our Latest Stock Analysis on Dr. Martens
Dr. Martens Stock Up 8.7%
The business has a 50-day simple moving average of GBX 55.34 and a two-hundred day simple moving average of GBX 62.85. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The company has a market capitalization of £795.54 million, a price-to-earnings ratio of 11.62, a PEG ratio of 6.40 and a beta of 0.11.
Dr. Martens (LON:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. As a group, equities analysts predict that Dr. Martens plc will post 2.5809394 EPS for the current year.
Dr. Martens Cuts Dividend
The company also recently disclosed a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were paid a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date was Thursday, March 6th. Dr. Martens's payout ratio is currently 42.53%.
Insiders Place Their Bets
In related news, insider Giles Wilson acquired 32,640 shares of the company's stock in a transaction dated Tuesday, March 25th. The stock was bought at an average price of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,857.07). Over the last 90 days, insiders purchased 33,206 shares of company stock valued at $1,792,771. Corporate insiders own 4.36% of the company's stock.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Recommended Stories
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
